文章摘要

参考文献/References

[1］ Owan TE, Hodge DO, Herges RM, et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction［J］. N Engl J Med, 2006, 355(3):251-259.

［2］ Owan TE, Redfield MM. Epidemiology of diastolic heart failure［J］. Prog Cardiovasc Dis, 2005, 47(5):320-332.

［3］ Bhatia RS, Tu JV, Lee DS, et al. Outcome of heart failure with preserved ejection fraction in a population based study［J］. N Engl J Med, 2006, 355(3):260-269.

［4］ Sandesson JE. Heart failure with a normal ejection fraction［J］. Heart, 2007, 93(2):155-158.

［5］ Heart Faliure Society of American: Executive summary: HFSA 2006 comprehensive Heart Failure practice Guideline［J］. J Card Fail, 2006, 12(1):10-38.

［6］ Hunt SA, Abrabam WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society［J］. Circulation, 2005, 112(12):e154-e235.

［7］ Melenovsky V, Bortaug B, Rosen B, et al. Cardiovascular features of heart faliure with preserved ejection fraction versus non-failing hypertesion left ventricular hypertrophy in the urban Baltimore community［J］. J Am Coll Cardiol, 2007, 49(2):198-207.

［8］ O’Rourke RA, Dell’Italia LJ. Diagnosis and management of right ventricular myocardial infarction［J］. Curr Probl Cardiol, 2004, 29(1):6-47.

［9］杨玉霞,杨丽霞,齐峰,等. 左房扩大在冠心病舒张性心力衰竭中的临床意义［J］. 心脏杂志, 2006, 18(14):445-450.

［10］Kass DA, Bronzwaer JG, Paulus WJ. What mechanisms underline diastolic dysfunction in heart failure?［J］. Circ Res, 2004, 94(12):1533-1542.

［11］Katz AM, Zile MR. New molecular mechanism in diastolic heart failure［J］. Circulation, 2006, 113(16):1922-1925.

［12］Aurigemma GP, Zile MR, Gaasch WH. Contractile behavior in the left ventricle in diastolic heart failure: with emphasis on regional systolic fraction［J］. Circulation, 2006, 113(2):296-340.

［13］臧益民,朱妙章,袁丽君,等. 心脏无创功能检测的研究进展［J］. 心脏杂志, 2005, 17(3):292-300.

［14］Munagala VK, Burnett Jc Jr, Redfield MM. The natriuretic peptides in cardiovascular medicine［J］. Curr Probl Cardiol, 2004, 29(12):707-769.

［15］Brubaker PH, Joo KC, Stewart KP, et al. Chronotropic incompetence and its contribution to exercise intolerance in older heart failure patients［J］. J Cardioplum Rehabil, 2006, 26(2):86-89.

［16］Borlang BA, Melenovsky V, Rusoell SD, et al. Impaired chronotropic and vasodilator reserve limit exercise capacity in patients with heart failure and a preserved ejection fraction［J］. Circulation, 2006, 114(20):2138-2147.

［17］Paulus WJ, Tochpe C, Sanderson JE, et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography association of the European Society of Cardiology［J］. Eur Heart J, 2007, 28(20):2539-2550.

［18］Yusuf S, Pfeffer MA, Swedberg K, et al. Effects of candesartan in patients with chronic heart failure and preserved left ventricular ejection fraction: The CHARM-Preserved trial［J］. Lancet, 2003, 362(9386):777-781.

［19］Little WC, Brucks S. Therapy for diastolic heart failure［J］. Prog Cardiovasc Dis, 2005, 47(6):380-388.

［20］Fukuta H, Sane DC, Brucks S, et al. Statin therapy may be associated with lower mortality in patients with diastolic heart failure: A preliminary report［J］. Circulation, 2005, 112(3):357-363.

［21］单培仁, 胡刘华, 何奔. 钠尿肽受体及其在心力衰竭中的作用和意义［J］. 心脏杂志, 2007, 19(6):732-734.

我们的网站为什么显示成这样？

正常射血分数心力衰竭的发病机制、诊断与治疗

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

文章信息/Info

参考文献/References

备注/Memo

常用功能

导航/Navigate

工具/Tools

统计/Statistics